Pipeline
Tes Pharma is focused on delivering proprietary first-in-class drug candidates for oncology, metabolic and renal diseases.
Target
(Disease) Disease
(Disease) Disease
Discovery
Preclinical
Clinical
FXR
TC-100 (INT-787)
Licensed to Intercept Pharmaceuticals
Metabolic
ACMSD
TES-AKI-01
Renal
NR2F6
TES-ONC-07
Cancer